In vitro activity of Gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria

2000 ◽  
Vol 38 (4) ◽  
pp. 243-253 ◽  
Author(s):  
Peter C. Fuchs ◽  
Arthur L. Barry ◽  
Steven D. Brown
Keyword(s):  
American Medical ◽  
North American ◽  
Vitro Activity ◽  
Disk Diffusion ◽  
In Vitro Activity ◽  
Bacterial Isolates ◽  
Diffusion Test ◽  
Disk Diffusion Test ◽  
Medical Centers

Multicenter Study to Assess the in vitro Activity of Tigecycline by Disk Diffusion Test against Clinical Isolates from Argentina

Chemotherapy ◽  
2009 ◽  
Vol 55 (1) ◽  
pp. 20-27 ◽  
Author(s):  
Liliana Fernández Canigia ◽  
Sara Kaufman ◽  
Liliana Lanata ◽  
Carlos Vay ◽  
Marta Giovanakis ◽  
...  
Keyword(s):  
Multicenter Study ◽  
Vitro Activity ◽  
Clinical Isolates ◽  
Disk Diffusion ◽  
In Vitro Activity ◽  
Diffusion Test ◽  
Disk Diffusion Test

scholarly journals In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, Italy

2009 ◽  
Vol 53 (4) ◽  
pp. 1657-1659 ◽  
Author(s):  
Narcisa Mandras ◽  
Vivian Tullio ◽  
Valeria Allizond ◽  
Daniela Scalas ◽  
Giuliana Banche ◽  
...  
Keyword(s):  
Clinical Isolates ◽  
Disk Diffusion ◽  
In Vitro Activity ◽  
High Susceptibility ◽  
Diffusion Test ◽  
Candida Spp ◽  
Disk Diffusion Test ◽  
Disk Diffusion Testing ◽  
Fluconazole Resistant

ABSTRACT The in vitro activities of fluconazole and voriconazole against 1,024 clinical isolates of Candida spp. were determined by the agar disk diffusion test using the Clinical and Laboratory Standards Institute (CLSI) M44-A guidelines. The results of this investigation demonstrated the broad-spectrum in vitro activity of voriconazole, relative to that of fluconazole, against yeasts tested, in particular fluconazole-resistant isolates, such as Candida krusei that showed high susceptibility to voriconazole. The situation in Turin, Italy, is quite similar to that of the rest of Italy, reflecting the worldwide trend.

scholarly journals In Vitro Activities of Clinafloxacin against Contemporary Clinical Bacterial Isolates from 10 North American Centers

1998 ◽  
Vol 42 (5) ◽  
pp. 1274-1277 ◽  
Author(s):  
Peter C. Fuchs ◽  
Arthur L. Barry ◽  
Steven D. Brown
Keyword(s):  
North American ◽  
Disk Diffusion ◽  
Aerobic Bacteria ◽  
Bacterial Isolates ◽  
Broth Microdilution ◽  
Medical Centers ◽  
Data Support ◽  
Facultative Anaerobic

ABSTRACT Clinafloxacin was more active than ciprofloxacin against 4,213 aerobic and facultative anaerobic bacterial isolates from 10 medical centers, as tested by broth microdilution and disk diffusion methods. The percentage of 201 anaerobes susceptible to clinafloxacin by broth microdilution was comparable to cefoxitin. Our data support the proposed disk diffusion interpretive criteria for aerobic bacteria with 5-μg clinafloxacin disks.

scholarly journals In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

2001 ◽  
Vol 45 (6) ◽  
pp. 1915-1918 ◽  
Author(s):  
Peter C. Fuchs ◽  
Arthur L. Barry ◽  
Steven D. Brown
Keyword(s):  
American Medical ◽  
North American ◽  
Half Life ◽  
Clinical Isolates ◽  
Bacterial Isolates ◽  
Gram Positive ◽  
Gram Positive Bacteria ◽  
Medical Centers ◽  
Amoxicillin Clavulanate

ABSTRACT This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L-749,345) with those of imipenem, amoxicillin-clavulanate, and ciprofloxacin against 5,558 recent clinical isolates from 11 North American medical centers. We confirmed the greater activity of ertapenem than of imipenem against the Enterobacteriaceae and the greater activity of imipenem against pseudomonads and gram-positive bacteria.

scholarly journals In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.

1984 ◽  
Vol 25 (4) ◽  
pp. 401-404 ◽  
Author(s):  
G M Eliopoulos ◽  
A Gardella ◽  
P DeGirolami ◽  
R C Moellering
Keyword(s):  
Vitro Activity ◽  
In Vitro Activity ◽  
Bacterial Isolates
Sign in / Sign up

Export Citation Format

Share Document